Erlotinib in wild type epidermal growth factor receptor non-small cell lung cancer: A systematic review
Background: Targeting epidermal growth factor receptors (EGFR) is an innovative approach to managing non-small cell lung cancer (NSCLC) which harbors EGFR mutation. However, the efficacy of these agents like erlotinib in patients without the mutation is not known. Methods: This systematic review in...
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artikel |
| Taal: | English |
| Gepubliceerd in: |
Wolters Kluwer Medknow Publications
2013-01-01
|
| Reeks: | Annals of Thoracic Medicine |
| Onderwerpen: | |
| Online toegang: | http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2013;volume=8;issue=4;spage=204;epage=208;aulast=Jazieh |